In this Issue:
Prediagnostic presentations of PD in primary care
CSF biomarkers and clinical PD progression
Improving functional disability and cognition in PD
Functional connectivity and cognitive decline in PD
Apathy and cognitive dysfunction in de novo PD
Action tremor motor signs and NMS in PD
Rasagiline + antidepressants in PD: NMS and tolerability
Disease penetrance of late-onset parkinsonism
APOE, MAPT and SNCA genes and cognitive performance in PD
Cholinesterase inhibitors and memantine in cognitive impairment/dementia
Cognitive and sensory load during complex gait adaptations in PD
ICD risk increased in PD with REM sleep behaviour disorder
Please login below to download this issue (PDF)